Researchers have developed a multistep protocol that converts human embryonic stem cells into insulin-producing cells that can reverse diabetes in approximately 40 days in an animal model—much faster than the 4 months required for cells produced with previous methods. The goal is to be able transplant these insulin-producing cells for the treatment of type 1 diabetes, researchers reported in a study published in the November issue of Nature Biotechnology.
High albumin levels, but within the normal range, can be used to identify young people with type 1 diabetes at risk of heart and kidney disease, according to a study published online ahead of print in Diabetes Care.
The extent to which patients are compliant with their type 1 diabetes treatment may have an effect on their mortality risk, according to the results of a recent study in the Journal of Diabetes and its Complications.
Researchers in Australia explored the frequency of decreasing insulin requirements in pregnant women with type 1 diabetes, as well as the effects on newborns. Read the latest updates on this topic here.
It is well known that exercising can help people with diabetes manage their condition—but could the order in which patients complete their workout regimen have an effect on blood glucose levels? Check out the findings from this recent study.
In 2012, a type 1 diabetes study was published comparing the effects of a mixture of insulin lispro (IL) and insulin glargine (IG) on glycemic control, and the subjects were young adults with type 1 diabetes. Is it helpful?
This information is not designed to replace a physician's independent judgment about the appropriateness or
risks of a procedure for a given patient. Always consult your doctor about your medical conditions. Vertical
Health & EndocrineWeb do not provide medical advice, diagnosis or treatment. Use of this website is
conditional upon your acceptance of our user agreement.